Expression and purification of bioactive soluble murine stem cell factor from recombinant Escherichia coli using thioredoxin as fusion partner

Publikation: Beitrag in FachzeitschriftArtikelForschungPeer-Review

Autorschaft

Organisationseinheiten

Externe Organisationen

  • Medizinische Hochschule Hannover (MHH)
  • Helmholtz-Zentrum für Infektionsforschung GmbH (HZI)
Forschungs-netzwerk anzeigen

Details

OriginalspracheEnglisch
Seiten (von - bis)1-8
Seitenumfang8
FachzeitschriftJournal of biotechnology
Jahrgang152
Ausgabenummer1-2
PublikationsstatusVeröffentlicht - 22 Jan. 2011

Abstract

Stem cell factor (SCF) known as the c-kit ligand, plays important roles in spermatogenesis, melanogenesis and early stages of hematopoiesis. As for the latter, SCF is essential for growth and expansion of hematopoietic stem and progenitor cells. We herein describe the production of recombinant murine SCF from Escherichia coli as soluble thioredoxin-fusion protein. The formation of insoluble and inactive inclusion bodies, usually observed when SCF is expressed in E. coli, was almost entirely prevented. After purification based on membrane adsorber technology, the fusion protein was subsequently cleaved by TEV protease in order to release mature mSCF. Following dialysis and a final purification step, the target protein was isolated in high purity. Bioactivity of mSCF was proven by different tests (MTT analogous assay, long-term proliferation assay) applying a human megakaryocytic cell line. Furthermore, the biological activity of the uncleaved fusion protein was tested as well. We observed a significant activity, even though it was less than the activity displayed by the purified mSCF. In summary, avoiding inclusion body formation we present an efficient production procedure for mSCF, one of the most important stem cell cytokines.

ASJC Scopus Sachgebiete

Zitieren

Expression and purification of bioactive soluble murine stem cell factor from recombinant Escherichia coli using thioredoxin as fusion partner. / Bals, Carola; Schambach, Axel; Meyer, Johann et al.
in: Journal of biotechnology, Jahrgang 152, Nr. 1-2, 22.01.2011, S. 1-8.

Publikation: Beitrag in FachzeitschriftArtikelForschungPeer-Review

Download
@article{9a663f84521c4d20b59d42084e2ad640,
title = "Expression and purification of bioactive soluble murine stem cell factor from recombinant Escherichia coli using thioredoxin as fusion partner",
abstract = "Stem cell factor (SCF) known as the c-kit ligand, plays important roles in spermatogenesis, melanogenesis and early stages of hematopoiesis. As for the latter, SCF is essential for growth and expansion of hematopoietic stem and progenitor cells. We herein describe the production of recombinant murine SCF from Escherichia coli as soluble thioredoxin-fusion protein. The formation of insoluble and inactive inclusion bodies, usually observed when SCF is expressed in E. coli, was almost entirely prevented. After purification based on membrane adsorber technology, the fusion protein was subsequently cleaved by TEV protease in order to release mature mSCF. Following dialysis and a final purification step, the target protein was isolated in high purity. Bioactivity of mSCF was proven by different tests (MTT analogous assay, long-term proliferation assay) applying a human megakaryocytic cell line. Furthermore, the biological activity of the uncleaved fusion protein was tested as well. We observed a significant activity, even though it was less than the activity displayed by the purified mSCF. In summary, avoiding inclusion body formation we present an efficient production procedure for mSCF, one of the most important stem cell cytokines.",
keywords = "Escherichia coli, Fusion protein, Membrane adsorber technology, Soluble protein expression, Stem cell factor, Thioredoxin",
author = "Carola Bals and Axel Schambach and Johann Meyer and Thomas Scheper and Ursula Rinas",
note = "Funding information: This work was partially supported by funds from the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) for the Cluster of Excellence RERBIRTH (Exc 62/1).",
year = "2011",
month = jan,
day = "22",
doi = "10.1016/j.jbiotec.2011.01.012",
language = "English",
volume = "152",
pages = "1--8",
journal = "Journal of biotechnology",
issn = "0168-1656",
publisher = "Elsevier",
number = "1-2",

}

Download

TY - JOUR

T1 - Expression and purification of bioactive soluble murine stem cell factor from recombinant Escherichia coli using thioredoxin as fusion partner

AU - Bals, Carola

AU - Schambach, Axel

AU - Meyer, Johann

AU - Scheper, Thomas

AU - Rinas, Ursula

N1 - Funding information: This work was partially supported by funds from the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) for the Cluster of Excellence RERBIRTH (Exc 62/1).

PY - 2011/1/22

Y1 - 2011/1/22

N2 - Stem cell factor (SCF) known as the c-kit ligand, plays important roles in spermatogenesis, melanogenesis and early stages of hematopoiesis. As for the latter, SCF is essential for growth and expansion of hematopoietic stem and progenitor cells. We herein describe the production of recombinant murine SCF from Escherichia coli as soluble thioredoxin-fusion protein. The formation of insoluble and inactive inclusion bodies, usually observed when SCF is expressed in E. coli, was almost entirely prevented. After purification based on membrane adsorber technology, the fusion protein was subsequently cleaved by TEV protease in order to release mature mSCF. Following dialysis and a final purification step, the target protein was isolated in high purity. Bioactivity of mSCF was proven by different tests (MTT analogous assay, long-term proliferation assay) applying a human megakaryocytic cell line. Furthermore, the biological activity of the uncleaved fusion protein was tested as well. We observed a significant activity, even though it was less than the activity displayed by the purified mSCF. In summary, avoiding inclusion body formation we present an efficient production procedure for mSCF, one of the most important stem cell cytokines.

AB - Stem cell factor (SCF) known as the c-kit ligand, plays important roles in spermatogenesis, melanogenesis and early stages of hematopoiesis. As for the latter, SCF is essential for growth and expansion of hematopoietic stem and progenitor cells. We herein describe the production of recombinant murine SCF from Escherichia coli as soluble thioredoxin-fusion protein. The formation of insoluble and inactive inclusion bodies, usually observed when SCF is expressed in E. coli, was almost entirely prevented. After purification based on membrane adsorber technology, the fusion protein was subsequently cleaved by TEV protease in order to release mature mSCF. Following dialysis and a final purification step, the target protein was isolated in high purity. Bioactivity of mSCF was proven by different tests (MTT analogous assay, long-term proliferation assay) applying a human megakaryocytic cell line. Furthermore, the biological activity of the uncleaved fusion protein was tested as well. We observed a significant activity, even though it was less than the activity displayed by the purified mSCF. In summary, avoiding inclusion body formation we present an efficient production procedure for mSCF, one of the most important stem cell cytokines.

KW - Escherichia coli

KW - Fusion protein

KW - Membrane adsorber technology

KW - Soluble protein expression

KW - Stem cell factor

KW - Thioredoxin

UR - http://www.scopus.com/inward/record.url?scp=79952042906&partnerID=8YFLogxK

U2 - 10.1016/j.jbiotec.2011.01.012

DO - 10.1016/j.jbiotec.2011.01.012

M3 - Article

C2 - 21262286

AN - SCOPUS:79952042906

VL - 152

SP - 1

EP - 8

JO - Journal of biotechnology

JF - Journal of biotechnology

SN - 0168-1656

IS - 1-2

ER -

Von denselben Autoren